|
Sections
Agriculture
Applied sciences
Arts
Belief
Business
Chronology
Culture
Education
Environment
Geography
Health
History
Humanities
Language
Law
Life
Mathematics
Nature
People
Politics
Science
Society
Technology
|
![]() euronews |
GlobeNewswire (press release)
Wed, 01 May 2013 22:39:37 -0700
In the report, Sanofi stated: “Given a recent competitor setback in the United States and extended development timelines for a Fix-Flex device, priority has been assigned to a Fixed-Ratio combination of Lantus®/Lyxumia®, currently in Phase II ...
| | |
Motley Fool
Sat, 18 May 2013 09:45:25 -0700
The French drugmaker already has a huge moneymaker insulin with Lantus. However, Lantus goes off-patent in a few years. Sanofi does have other diabetes products on the market and in the pipeline, but I think that an inhalable insulin would make a good ...
| | |
MarketWatch (press release)
Mon, 06 May 2013 05:02:34 -0700
Do NOT dilute or mix Lantus with any other insulin or solution. It will not work as intended and you may lose blood sugar control, which could be serious. Lantus must only be used if the solution is clear and colorless with no particles visible. Do not ...
| ![]() Scranton Times-Tribune |
Scranton Times-Tribune
Fri, 17 May 2013 01:06:20 -0700
Terese rechecks her sugar levels up to eight times throughout the day, and she injects insulin with a pen device between four and five times daily. Every night at 9:30, she injects Lantus by syringe to maintain her sugar while she sleeps. Proactive ...
| | |
A Sweet Life (blog)
Wed, 15 May 2013 04:24:22 -0700
One night while getting ready for bed I took the insulin pen that was next to the sink, where I usually left it, and injected myself with what I thought were 12 units of Lantus long acting insulin. The second I finished injecting I realized I had used ...
| | |
Seeking Alpha
Thu, 16 May 2013 15:20:47 -0700
His metformin isn't working for him anymore, he needs Lantus. And I watched that for a long time, and finally turned to the physician, I said, okay, how do you make that decision? And he kind of looked at me, and he goes, well, I've been at this for a ...
| | |
GlobeNewswire (press release)
Tue, 14 May 2013 23:37:47 -0700
After the end of the period, in May, Sanofi announced its decision to prioritize the Fixed-Ratio combination of Lantus®/Lyxumia® for Phase III initiation. Further development timelines will be shared at the time of the American Diabetes Association ...
| | |
NASDAQ
Wed, 15 May 2013 09:29:06 -0700
Sanofi's Lantus (insulin glargine), the leading long-acting insulin, posted sales of €4.9 billion ($6.1 billion) in 2012. Besides insulin, there are a host of anti-diabetic medications on the market designed to lower blood glucose levels; some of which ...
|
Oops, we seem to be having trouble contacting Twitter
|
|
You can talk about Lantus with people all over the world in our discussions.
|
